fda import alert green list glp-1 semaglutide tirzepatide 2025 Drug Recalls and Warnings: Recalls for Compounded and Tirzepatide, Wegovy; Facility Warning Letters FDA's green list cracks down

In one clinical trial, 5 mg per week tirzepatide was slightly more effective than 1 mg per week semaglutide in reducing body weight and glycated hemoglobin (HbA1c)

Treat these as warning signs that a source is not legitimate: no prescription required, a pharmacy located outside the United States, packaging that is damaged, opened, unlabeled in English, or missing an expiration date, and ingredient lists described only as proprietary blends

Clearly state which formulation the patient receives

However, cagrilintide's unique mechanism and long-acting formulation make the standard starting dose appropriate regardless of prior peptide exposure